The German stock market did not find a consistent direction on Tuesday. The Dax continued its hang below the 16,000 point mark and was trading virtually unchanged at 15,901.87 points in the afternoon. The MDax of medium-sized companies, however, fell by 0.92 percent to 26,151.85 points. The Eurozone index EuroStoxx 50 fell by around 0.2 percent.
The German stock market did not find a consistent direction on Tuesday. The Dax continued its hang below the 16,000 point mark and was trading virtually unchanged at 15,901.87 points in the afternoon. The MDax of medium-sized companies, however, fell by 0.92 percent to 26,151.85 points. The Eurozone index EuroStoxx 50 fell by around 0.2 percent.
New trial data for the cancer drug pelabresib caused Morphosys’ share price to fall to its lowest level since the beginning of April. The shares were recently down almost 25 percent and have therefore lost around half of their value in the last eight trading days.
The financial investor Permira continues to cash in on the software provider Teamviewer. By placing 13 million shares, the share falls from just under 21 to around 14 percent. The papers were offered for 13.90 euros each. They were recently quoted 9.3 percent lower and therefore below the placement price.
New targets by 2026 gave the share price of the defense company and automotive supplier Rheinmetall an increase of up to 5.8 percent and another record high of 295 euros. Most recently, the papers at the top of the Dax rose by 4.3 percent.
The euro recently rose to $1.0959. The European Central Bank had set the reference rate at 1.0928 the day before. On the bond market, the current yield rose from 2.61 percent the day before to 2.62 percent. The Rex bond index fell by 0.29 percent to 123.95 points. The Bund future rose by 0.10 percent to 131.04 points.
Source: Stern
